2018 - Reviewing Codes 1200 accommodation and presbyopia, in vivo and in vitro - VI 1210 adaptive optics: imaging science - VI 1220 adaptive optics: visual function and performance - VI 1230 allergic conjunctivitis - IM 1240 amblyopia - EY 1250 amblyopia: screening and epidemiology - EY 1260 AMD anti VEGF - RE 1270 AMD imaging - RE 1280 AMD therapies (excluding anti-vegf) - RE 1290 AMD: biochemical and molecular disease mechanisms - BI 1300 AMD: cell biology - RC 1310 AMD: clinical research - RE 1320 AMD: epidemiology - CL 1330 AMD: genetic studies - GEN 1340 AMD: immunobiology - IM 1350 AMD: new drugs, delivery systems, and mechanisms of action - PH 1360 AMD: pathology - RC 1370 AMD: preclinical studies - RC 1380 AMD: translational studies - RE 1390 anatomy: ocular structures excepting cornea, lens, retina - AP 1400 anatomy: orbital structures excepting extraocular muscles - AP 1410 angiogenesis - RC 1420 anterior segment epidemiology (non-cornea) - CL 1430 antiangiogenic agents - PH 1440 antibiotics/antivirals - PH 1450 anti-inflammatory agents - PH 1460 aqueous humor dynamics - PH 1470 autoimmune ocular disease - IM 1480 bacterial/parasitic infections - IM 1490 binocular vision, stereo, and depth cues - VI 1500 biochemistry, cell and molecular biology of ocular structures excepting CORNEA, lens, cornea - AP 1510 bipolar cell structure and function - VN 1520 blood flow - PH 1530 cataract surgery - LE 1540 cataract surgery: epidemiology - LE 1550 cataract surgery: surgical procedures - LE 1560 cataract: epidemiology - CL 1570 cataractogenesis - LE 1580 cataractogenesis: treatment prevention and treatmen - LE 1590 central visual pathways: structure and function - VN 1600 choroid: mechanisms in health and disease/cell biology and function - AP 1610 choroidal neovascularization - RE 1620 clinical trials: visual impairment and function - LV 1630 CNV: animal models and mechanisms - RC 1640 color vision - VI
1650 conjunctiva: cell biology, disease and surgery - CO 1660 contact lens - CO 1670 cornea surgery: refractive - CO 1680 corneal applied regenerative medicine - CO 1690 corneal biomechanics - CO 1700 corneal cell and molecular biology - CO 1710 corneal development and cell differentiation - CO 1720 corneal disease: epidemiology - CL 1730 corneal disease: pharmacology - PH 1740 corneal dystrophies and genetics - GEN 1750 corneal endothelium - CO 1760 corneal epithelium - CO 1770 corneal imaging and topography - CO 1780 corneal immunology - CO 1790 corneal immunology and infections - IM 1800 corneal neovascularization - CO 1810 corneal neuropathy: diabetic and other - CO 1820 corneal optics - VI 1830 corneal surgery: non-refractive - CO 1840 corneal wound repair and healing - CO 1850 corneal: stroma and keratocytes - CO 1860 cytokines and growth factors - PH 1870 diabetic macular edema anti VEGF - RE 1880 diabetic macular edema: clinical research - RE 1890 diabetic retinopathy: angiogenesis - RC 1900 diabetic retinopathy: biochemical and molecular disease mechanisms - BI 1910 diabetic retinopathy: cell biology - RC 1920 diabetic retinopathy: epidemiology - CL 1930 diabetic retinopathy: genetic studies - GEN 1940 diabetic retinopathy: medical - RE 1950 diabetic retinopathy: pharmacological agents, targets and mechanisms of action - PH 1960 diabetic retinopathy: preclinical studies - RC 1970 diabetic retinopathy: surgical - RE 1980 drug and gene delivery systems - PH 1990 drug delivery: iris-ciliary body/intraocular fluids/posterior segment - PH 2000 dry eye, clinical - CO 2010 dry eye, non-clinical - CO 2020 electrophysiology - VN 2030 electroretinography of disease - VN 2040 electroretinography: basic mechanisms and techniques - VN 2050 embryology of ocular structures - AP 2060 endophthalmitis: clinical - RE 2070 epigenetics and chromatin structure in ocular function/disease - BI 2080 extraocular muscles and associated tissues - EY 2090 eye movements - EY 2100 eye movements: nystagmus - EY 2110 Fuchs corneal dystrophy pathobiology - CO
2120 functional consequences of vision loss - CL 2130 ganglion cell structure and function - VN 2140 gene editing - BI 2150 gene therapies - BI 2160 gene therapy and delivery - PH 2170 gene therapy: visual impairment and function - LV 2180 gene variants: sequencing, function, or phenotype - BI 2190 genetic epidemiology - CL 2200 genetics - GEN 2210 genome structure, functional/translational genomics, transcriptomics - BI 2220 glaucoma: biochemistry and molecular biology, genomics and proteomics - BI 2230 glaucoma: biomechanics - GL 2240 glaucoma: clinical drug studies and clinical trials - GL 2250 glaucoma: electrophysiology - GL 2260 glaucoma: epidemiology - CL 2270 glaucoma: genetics - GEN 2280 glaucoma: imaging - GL 2290 glaucoma: IOP measurement and characterization - GL 2300 glaucoma: laser therapy - GL 2310 glaucoma: neurodegeneration - GL 2320 glaucoma: neuroprotection - GL 2330 glaucoma: ocular blood flow - GL 2340 glaucoma: pharmacological intervention or cellular mechanism - GL 2350 glaucoma: structure/function relationships - GL 2360 glaucoma: surgery or wound healing - GL 2370 glaucoma: trabecular meshwork and ciliary body - GL 2380 glaucoma: visual fields and psychophysics - GL 2390 glaucoma: visual impairment and function LV 2400 glial cells - RC 2410 health care delivery and economic research - CL 2420 horizontal and amacrine cells: structure and function - VN 2430 hypoxia - PH 2440 image assessment: visual factors - VI 2450 image understanding - VI 2460 imaging retinal activity - VI 2470 imaging: adaptive optics - MOI 2480 imaging: animal models - MOI 2490 imaging: clinical applications - MOI 2500 imaging: functional imaging - MOI 2510 imaging: image processing and analysis methodologies - MOI 2520 imaging: magnetic resonance imaging - MOI 2530 imaging: new technologies and techniques - MOI 2540 imaging: optical coherence tomography - MOI 2550 imaging: other - MOI 2560 imaging: posterior segment, clinical - RE 2570 imaging: ultrasound - MOI 2580 immunohistochemistry and other tissue-based diagnostic techniques - AP
2590 implant delivery systems - PH 2600 innate immunity to pathogens - IM 2610 intraocular pressure/physiology pharmacology - PH 2620 intravitreal/periocular local therapies (excluding anti-vegf) - RE 2630 intrinsically photoreceptive ganglion cell structure and function - VN 2640 IOL and crystalline lens optics - VI 2650 ion channels, aquaporins, membrane properties and epithelial transport - PH 2660 ischemia/reperfusion and oxidative stress - PH 2670 keratoconus and collagen crosslinking - CO 2680 lacrimal gland and meibomian gland - CO 2690 laser - RE 2700 lens - LE 2710 lens accommodation - LE 2720 lens cytoskeleton - LE 2730 lens development and differentiation - LE 2740 lens epithelium - LE 2750 lens fiber cells - LE 2760 lens physiology - LE 2770 lens proteins: normal and pathogenic biochemistry - LE 2780 low visio: questionnaires and quality of life - LV 2790 low vision: mobility and driving - LV 2800 low vision: reading - LV 2810 low vision: visual function - LV 2820 low vision: visual psychophysics - VI 2830 macular degeneration: inherited - RC 2840 macular diseases excluding AMD - RE 2850 macular edema - RE 2860 micelles, liposomes, microparticle and colloidal delivery systems - PH 2870 microbiology/immunology translational - IM 2880 microglia / innate immunity - RC 2890 molecular and biochemical mechanisms of retinal disease - BI 2900 molecular pharmacology / receptors / signal transduction - PH 2910 myopia: animal models - AP 2920 myopia: biochemistry, cell and molecular biology - AP 2930 myopia: epidemiology - CL 2940 myopia: genetics - AP 2950 myopia: imaging - AP 2960 myopia: light-dependent mechanisms - AP 2970 myopia: ocular biometry - AP 2980 myopia: RPE/choroid/sclera AP 2990 myopia: structure/function relationships - AP 3000 neural retina: dysfunction in disease - VN 3010 neuro-ophthalmology - EY 3020 neuro-ophthalmology: idiopathic intracranial hypertension - EY 3030 neuro-ophthalmology: optic neuropathy excepting glaucoma - EY 3040 neuro-ophthalmology: papilledema - EY 3050 neuro-ophthalmology: pupillometry - EY
3060 neuro-ophthalmology: visual impairment and function - LV 3070 neuro-ophthalology: pediatric - EY 3080 neuroprotection - RC 3090 non-infectious uveitis - IM 3100 ocular development - AP 3110 ocular proteomics, lipidomics, metabolomics and systems biology - BI 3120 ocular surface disease and microbiome - CO 3130 ocular surface health and disease - CO 3140 ocular therapeutics and chemical biology - BI 3150 ocular toxicology - PH 3160 ocular trauma: epidemiology - CL 3170 ocular vasculature including lymphatics: development, structure and function - AP 3180 oculoplastics - EY 3190 oculoplastics: therapeutic approaches and clinical trials - EY 3200 optic nerve: struture and function - AP 3210 optogenetics - VN 3220 orbital disease/surgery - EY 3230 pathologic myopia: clinical manifestations and treatment - RE 3240 pediatric ophthalmology - EY 3250 pediatric ophthalmology: epidemiology - CL 3260 pediatric ophthalmology: imaging - EY 3270 peripheral vision - VI 3280 photoreceptor degeneration/apoptosis: cell biology and pathology - RC 3290 photoreceptors: development - RC 3300 photoreceptors: structure and function - VN 3310 physiological optics: aberrations - VI 3320 physiological optics: optical design and models - VI 3330 physiological optics: refractive error myopia/ocular dimensions - VI 3340 posterior capsular opacification (PCO) - LE 3350 proliferative vitreoretinopathy - RE 3360 protein interactions/ trafficking/ transfer and protein modifications - BI 3370 ptosis - EY 3380 refractive error: epidemiology - CL 3390 refractive error: structure/function relationships - AP 3400 refractive error: imaging - AP 3410 regulation of ocular genes, microrna/non-coding RNA-mediated control - BI 3420 retina/rpe: biochemistry and molecular biology - BI 3430 retina/rpe: cell death, autophagy, oxidation, ER stress - RC 3440 retina/rpe: development - RC 3450 retina/rpe: genetic studies - GEN 3460 retina/rpe: metabolism - RC 3470 retina/rpe: new drugs, mechanisms of action, and toxicity - PH 3480 retina/rpe: transplantation, clinical - RE 3490 retina: cell biology - RC 3500 retina: physiology/pharmacology - PH 3510 retinal (neural and RPE) degeneration - RC 3520 retinal adaptation, modulation and circadian rhythms - VN
3530 retinal circuitry - VN 3540 retinal detachment: basic research - RE 3550 retinal detachment: clinical - RE 3560 retinal development: cell biology and morphology - RC 3570 retinal disease: epidemiology - CL 3580 retinal diseases visual impairment and function LV 3590 retinal image quality and metrics - VI 3600 retinal inflammation and infection - IM 3610 retinal prostheses - RE 3620 retinal prostheses: visual impairment and function - LV 3630 retinal synapses: chemical and electrical - VN 3640 retinal vascular diseases (excluding diabetic retinopathy) - RE 3650 retinitis pigmentosa: clinical - RE 3660 retinoids and carotenoids: phototransduction, visual cycle and macular pigment - BI 3670 retinopathy of prematurity: clinical - RE 3680 ROP-basic mechanisms - RC 3690 RPE: cell biology - RC 3700 stem cells - RC 3710 stem cells and gene therapy: clinical - RE 3720 strabismus - EY 3730 strabismus: basic mechanisms and animal models - EY 3740 strabismus: therapeutic approaches and clinical trials - EY 3750 tear firm - CO 3760 thyroid eye disease - EY 3770 trauma: cell and molecular biology - RC 3780 trauma: posterior segment, clinical - RE 3790 tumors: cell culture and animal models - AP 3800 tumors: eyelids, ocular surface, conjunctiva, and ocular adnexa - AP 3810 tumors: imaging and therapeutics - AP 3820 tumors: molecular diagnostics and pathology/genetic studies - AP 3830 tumors: orbit/nos - AP 3840 tumors: retinoblastoma - AP 3850 tumors: uveal melanoma- AP 3860 uveitis: epidemiology, quality of life - IM 3870 uveitis: therapeutics - IM 3880 viral/fungal infections - IM 3890 visual and retinal processing - VN 3900 visual behavior - VN 3910 visual factors in virtual reality - VI 3920 visual function and quality of life - CL 3930 visual function in normal and aging vision - VI 3940 visual function in presence of ocular disease - VI 3950 visual impairment: prevalence, incidence and risk factors - CL 3960 visual perception and adaptation - VI 3970 visual psychophysics: fundamental and applied - VI 3980 visual psychophysics: spatial and temporal vision - VI 3990 vitreoretinal interface disease - RE
4000 vitreoretinal surgery: clinical - RE 4010 vitreoretinal surgery: novel approaches - RE